Oppenheimer analyst Suraj Kalia downgraded DexCom (NASDAQ: DXCM) from Outperform to Perform.The analyst comments "We are assuming coverage of DXCM ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE